MCRB
Price
$0.73
Change
-$0.04 (-5.19%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
124.19M
Earnings call today
RIGL
Price
$19.59
Change
-$0.93 (-4.53%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
349.94M
Ad is loading...

MCRB vs RIGL

Header iconMCRB vs RIGL Comparison
Open Charts MCRB vs RIGLBanner chart's image
Seres Therapeutics
Price$0.73
Change-$0.04 (-5.19%)
Volume$2K
Capitalization124.19M
Rigel Pharmaceuticals
Price$19.59
Change-$0.93 (-4.53%)
Volume$2.16K
Capitalization349.94M
MCRB vs RIGL Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCRB vs. RIGL commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Buy and RIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (MCRB: $0.67 vs. RIGL: $22.08)
Brand notoriety: MCRB and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 167% vs. RIGL: 96%
Market capitalization -- MCRB: $124.19M vs. RIGL: $349.94M
MCRB [@Biotechnology] is valued at $124.19M. RIGL’s [@Biotechnology] market capitalization is $349.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • MCRB’s TA Score: 4 bullish, 4 bearish.
  • RIGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MCRB and RIGL are a good buy in the short-term.

Price Growth

MCRB (@Biotechnology) experienced а -13.72% price change this week, while RIGL (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

MCRB is expected to report earnings on Apr 30, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($350M) has a higher market cap than MCRB($124M). RIGL YTD gains are higher at: 31.272 vs. MCRB (-19.362). RIGL has higher annual earnings (EBITDA): 13.7M vs. MCRB (-51.72M). MCRB has more cash in the bank: 66.8M vs. RIGL (61.1M). RIGL has less debt than MCRB: RIGL (60.2M) vs MCRB (93.6M). RIGL has higher revenues than MCRB: RIGL (157M) vs MCRB (126M).
MCRBRIGLMCRB / RIGL
Capitalization124M350M35%
EBITDA-51.72M13.7M-378%
Gain YTD-19.36231.272-62%
P/E RatioN/A19.79-
Revenue126M157M80%
Total Cash66.8M61.1M109%
Total Debt93.6M60.2M155%
FUNDAMENTALS RATINGS
MCRB vs RIGL: Fundamental Ratings
MCRB
RIGL
OUTLOOK RATING
1..100
5274
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8041
P/E GROWTH RATING
1..100
10074
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (55) in the Biotechnology industry is somewhat better than the same rating for RIGL (88). This means that MCRB’s stock grew somewhat faster than RIGL’s over the last 12 months.

MCRB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RIGL (100). This means that MCRB’s stock grew similarly to RIGL’s over the last 12 months.

MCRB's SMR Rating (100) in the Biotechnology industry is in the same range as RIGL (100). This means that MCRB’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for MCRB (80). This means that RIGL’s stock grew somewhat faster than MCRB’s over the last 12 months.

RIGL's P/E Growth Rating (74) in the Biotechnology industry is in the same range as MCRB (100). This means that RIGL’s stock grew similarly to MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBRIGL
RSI
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
84%
Bearish Trend 7 days ago
89%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
79%
MACD
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 7 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 28 days ago
85%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
73%
Bearish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
77%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
-10.50%
RIGL - MCRB
38%
Loosely correlated
-1.30%
ATNM - MCRB
37%
Loosely correlated
+3.77%
OTLK - MCRB
32%
Poorly correlated
+3.52%
BMEA - MCRB
27%
Poorly correlated
+4.55%
QURE - MCRB
27%
Poorly correlated
+3.94%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-1.30%
CLNN - RIGL
92%
Closely correlated
-1.62%
DARE - RIGL
88%
Closely correlated
N/A
PHIO - RIGL
84%
Closely correlated
N/A
AZTR - RIGL
84%
Closely correlated
+1.52%
IMRN - RIGL
82%
Closely correlated
-5.84%
More